文献速递心脑血管急症重症综合管理与镇静镇痛

急性脑损伤中输血策略启动时机:TRAIN研究亚组分析

Timing of Transfusion Strategy Initiation in Acute Brain Injury: A Subanalysis of the TRAIN Study.
PubMed 文献 · Neurocrit Care · 2026-09-28
一句话结论急性脑损伤患者中,宽松输血策略(Hb<9 g/dL触发)在不同启动时机均与更低的180天不良神经预后概率相关,早期启动时数值上更强。

这是国际多中心TRAIN随机临床试验的事后探索性分析,纳入820例成人创伤性脑损伤、动脉瘤性蛛网膜下腔出血或脑出血患者,随机接受Hb<9 g/dL(宽松策略LTS)或Hb<7 g/dL(限制性策略RTS)触发输血。暴露为ICU入院至随机化的时间(早期≤3天 vs 晚期>3天)。主要终点为180天不良神经预后(GOSE 1-5分)。LTS在早期和晚期随机化组均与更低的不良预后概率相关,早期组OR 0.51(95%CI 0.34-0.76),但策略与时机交互作用无统计学意义(p=0.88)。

要点

  • 成人急性脑损伤(TBI、aSAH、ICH)中,LTS(Hb<9 g/dL触发)较RTS(Hb<7 g/dL触发)与更低180天不良神经预后概率相关,早期随机化组OR 0.51(95%CI 0.34-0.76)。
  • 早期随机化组(≤3天)中LTS还与更少脑缺血事件(OR 0.33,95%CI 0.14-0.77)、更短机械通气和ICU停留相关。
  • 晚期随机化组(>3天)中LTS与更低脓毒症(OR 0.33,95%CI 0.13-0.86)和ARDS(OR 0.39,95%CI 0.2-0.78)发生率相关。
  • 输血策略与随机化时机的交互作用无统计学意义(p=0.88),连续建模未显示随机化时间与不良预后之间的明确关系。
  • 探索性暴露-反应分析提示ICU期间Hb>9 g/dL累积暴露越多,不良预后概率越低,但需前瞻性研究验证。

适用人群与场景

  • 成人创伤性脑损伤、动脉瘤性蛛网膜下腔出血或脑出血患者,来自国际多中心TRAIN随机临床试验,纳入ICU后随机化。

诊断标准与关键阈值

  • 宽松输血策略(LTS):血红蛋白阈值低于9 g/dL时触发输血;限制性输血策略(RTS):血红蛋白阈值低于7 g/dL时触发输血。
  • 早期随机化定义为ICU入院至随机化≤3天,晚期定义为>3天。
  • 主要终点不良神经预后定义为180天Glasgow结局扩展量表(GOSE)评分1-5分。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:国际多中心TRAIN随机临床试验的事后探索性分析,样本量820例。
  • 干预与对照:LTS(Hb<9 g/dL触发输血)vs RTS(Hb<7 g/dL触发输血)。
  • 主要终点:LTS在早期和晚期随机化组均与更低的不良神经预后概率相关,早期组OR 0.51(95%CI 0.34-0.76),但交互作用p=0.88。
  • 关键次要终点:早期组LTS与更少脑缺血事件(OR 0.33,95%CI 0.14-0.77)、更短机械通气和ICU停留相关;晚期组LTS与更低脓毒症(OR 0.33,95%CI 0.13-0.86)和ARDS(OR 0.39,95%CI 0.2-0.78)相关。
  • 探索性分析:ICU期间Hb>9 g/dL累积暴露越多与更低不良预后概率相关;连续建模未显示随机化时间与不良预后的明确关系。

证据类型、等级与局限

  • 证据类型:国际多中心随机临床试验的事后探索性亚组分析。
  • 局限:事后探索性分析,非预设主要分析,策略与时机交互作用无统计学意义(p=0.88),需前瞻性研究专门验证时机问题。

对床旁实践的改变

  • 在成人急性脑损伤(TBI、aSAH、ICH)ICU患者中,宽松输血策略(Hb<9 g/dL触发)在不同启动时机均与更低不良神经预后概率相关,早期(≤3天)启动时数值上更强,但交互作用未达统计学显著。
  • 早期启动LTS可能减少脑缺血事件、缩短机械通气和ICU停留;晚期启动LTS可能降低脓毒症和ARDS发生率,但这些均为探索性亚组结果。
  • 原文未提供具体输血剂量、疗程或目标血红蛋白维持值,临床决策需结合个体情况。

指南或共识出处

  • TRAIN随机临床试验(国际多中心),本文为其事后探索性分析。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: Recent randomized trials suggested that a liberal transfusion strategy (LTS) may be beneficial compared with a restrictive strategy (RTS) in patients with acute brain injury (ABI), although results remain inconsistent across studies. The aim of our study was to investigate whether the time of initiation of these transfusion strategies might influence neurological outcomes in patients with ABI.

METHODS: This was a post hoc exploratory analysis of the international, multicenter TRAIN randomized clinical trial. Adult patients with traumatic brain injury, aneurysmal subarachnoid hemorrhage, or intracerebral hemorrhage were randomized to receive transfusion at a hemoglobin threshold of either below 9 g/dL (LTS) or below 7 g/dL (RTS). The exposure of interest was time from intensive care unit (ICU) admission to randomization, analyzed both categorically (i.e., as early, ≤ 3 days vs. late, > 3 days) or as a continuous variable. The primary outcome was the occurrence of unfavorable neurological outcome at 180 days (UO), defined as a Glasgow Outcome Scale-Extended score of 1-5. Associations were examined using multivariable logistic regression, propensity score matching, generalized additive models, and segmented regression. A formal interaction between transfusion strategy and timing was tested to assess effect modification.

RESULTS: Among the 820 included patients, baseline characteristics were well balanced between transfusion strategies within early and late randomization groups. LTS was consistently associated with a lower probability of UO compared with RTS, both in early- and late-randomization group, although point estimates suggested a numerically stronger association when randomization occurred earlier [odds ratio (OR) 0.51, 95% confidence interval (CI) 0.34-0.76]. LTS was associated with fewer cerebral ischemic events (OR 0.33, 95% CI 0.14-0.77), shorter mechanical ventilation and ICU stay in the early-randomization group, whereas in the late-randomization group LTS was associated with lower rates of sepsis (OR 0.33, 95% CI 0.13-0.86) and ARDS (OR 0.39, 95% CI 0.2-0.78]). Continuous modeling showed no clear relationship between time to randomization and UO. The interaction between transfusion strategy and timing was not statistically significant (p = 0.88). Exploratory exposure-response analyses suggested that greater cumulative exposure to hemoglobin levels above 9 g/dL during the ICU stay was associated with a lower probability of UO.

CONCLUSIONS: In patients with ABI, a LTS was associated with a lower probability of unfavorable long-term neurological outcome across different times to randomization. Timing to randomization may influence the impact of transfusion strategies and the occurrence of some adverse events, although prospective studies specifically designed to address this question are needed to confirm it.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Zattera L, Romero-Garcia N, Gabarrus A, et al. Timing of Transfusion Strategy Initiation in Acute Brain Injury: A Subanalysis of the TRAIN Study. Neurocrit Care. 2026. PMID: 42806263. doi:10.1007/s12028-026-02651-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。